267 related articles for article (PubMed ID: 16361284)
1. Influence of intermediate and uninterrupted FMR1 CGG expansions in premature ovarian failure manifestation.
Bodega B; Bione S; Dalprà L; Toniolo D; Ornaghi F; Vegetti W; Ginelli E; Marozzi A
Hum Reprod; 2006 Apr; 21(4):952-7. PubMed ID: 16361284
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the molecular parameters that could predict the risk of manifesting premature ovarian failure in female premutation carriers of fragile X syndrome.
Tejada MI; García-Alegría E; Bilbao A; Martínez-Bouzas C; Beristain E; Poch M; Ramos-Arroyo MA; López B; Fernandez Carvajal I; Ribate MP; Ramos F
Menopause; 2008; 15(5):945-9. PubMed ID: 18427356
[TBL] [Abstract][Full Text] [Related]
3. Premature ovarian failure and fragile X female premutation carriers: no evidence for a skewed X-chromosome inactivation pattern.
Rodriguez-Revenga L; Madrigal I; Badenas C; Xunclà M; Jiménez L; Milà M
Menopause; 2009; 16(5):944-9. PubMed ID: 19373114
[TBL] [Abstract][Full Text] [Related]
4. Ovarian dysfunction and FMR1 alleles in a large Italian family with POF and FRAXA disorders: case report.
Miano MG; Laperuta C; Chiurazzi P; D'Urso M; Ursini MV
BMC Med Genet; 2007 Apr; 8():18. PubMed ID: 17428316
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and instability of fragile X alleles: implications for offering fragile X prenatal diagnosis.
Cronister A; Teicher J; Rohlfs EM; Donnenfeld A; Hallam S
Obstet Gynecol; 2008 Mar; 111(3):596-601. PubMed ID: 18310361
[TBL] [Abstract][Full Text] [Related]
6. Correlation of triple repeats on the FMR1 (fragile X) gene to ovarian reserve: a new infertility test?
Gleicher N; Weghofer A; Oktay K; Barad DH
Acta Obstet Gynecol Scand; 2009; 88(9):1024-30. PubMed ID: 19642041
[TBL] [Abstract][Full Text] [Related]
7. Anti-Mullerian hormone indicates early ovarian decline in fragile X mental retardation (FMR1) premutation carriers: a preliminary study.
Rohr J; Allen EG; Charen K; Giles J; He W; Dominguez C; Sherman SL
Hum Reprod; 2008 May; 23(5):1220-5. PubMed ID: 18310677
[TBL] [Abstract][Full Text] [Related]
8. A pilot study of premature ovarian senescence: II. Different genotype and phenotype for genetic and autoimmune etiologies.
Gleicher N; Weghofer A; Barad DH
Fertil Steril; 2009 May; 91(5):1707-11. PubMed ID: 18384784
[TBL] [Abstract][Full Text] [Related]
9. The significance of fragile X mental retardation gene 1 CGG repeat sizes in the normal and intermediate range in women with primary ovarian insufficiency.
Voorhuis M; Onland-Moret NC; Janse F; Ploos van Amstel HK; Goverde AJ; Lambalk CB; Laven JS; van der Schouw YT; Broekmans FJ; Fauser BC;
Hum Reprod; 2014 Jul; 29(7):1585-93. PubMed ID: 24812319
[TBL] [Abstract][Full Text] [Related]
10. Reproductive health of adolescent girls who carry the FMR1 premutation: expected phenotype based on current knowledge of fragile x-associated primary ovarian insufficiency.
De Caro JJ; Dominguez C; Sherman SL
Ann N Y Acad Sci; 2008; 1135():99-111. PubMed ID: 18574214
[TBL] [Abstract][Full Text] [Related]
11. Do etiologies of premature ovarian aging (POA) mimic those of premature ovarian failure (POF)?
Gleicher N; Weghofer A; Oktay K; Barad D
Hum Reprod; 2009 Oct; 24(10):2395-400. PubMed ID: 19617205
[TBL] [Abstract][Full Text] [Related]
12. Very early premature ovarian failure in two sisters compound heterozygous for the FMR1 premutation.
Van Esch H; Buekenhout L; Race V; Matthijs G
Eur J Med Genet; 2009; 52(1):37-40. PubMed ID: 19041959
[TBL] [Abstract][Full Text] [Related]
13. Study of FMR1 gene association with ovarian dysfunction in a sample from the Basque Country.
Barasoain M; Barrenetxea G; Huerta I; Télez M; Carrillo A; Pérez C; Criado B; Arrieta I
Gene; 2013 May; 521(1):145-9. PubMed ID: 23537988
[TBL] [Abstract][Full Text] [Related]
14. [The use of DNA analysis for diagnostics of hereditary premature ovarian failure].
Livshyts' HB; Kravchenko SA; Hryshchenko NV; Sudoma IA
Tsitol Genet; 2005; 39(2):59-63. PubMed ID: 16161415
[TBL] [Abstract][Full Text] [Related]
15. Fragile X premutations and (TA)n estrogen receptor polymorphism in women with ovarian dysfunction.
Syrrou M; Georgiou I; Patsalis PC; Bouba I; Adonakis G; Pagoulatos GN
Am J Med Genet; 1999 May; 84(3):306-8. PubMed ID: 10331614
[TBL] [Abstract][Full Text] [Related]
16. The effect of CGG repeat number on ovarian response among fragile X premutation carriers undergoing preimplantation genetic diagnosis.
Bibi G; Malcov M; Yuval Y; Reches A; Ben-Yosef D; Almog B; Amit A; Azem F
Fertil Steril; 2010 Aug; 94(3):869-74. PubMed ID: 19481741
[TBL] [Abstract][Full Text] [Related]
17. Is the immunological noise of abnormal autoimmunity an independent risk factor for premature ovarian aging?
Gleicher N; Weghofer A; Oktay K; Barad DH
Menopause; 2009; 16(4):760-4. PubMed ID: 19197218
[TBL] [Abstract][Full Text] [Related]
18. Premature ovarian failure (POF) and fragile X premutation females: from POF to to fragile X carrier identification, from fragile X carrier diagnosis to POF association data.
Uzielli ML; Guarducci S; Lapi E; Cecconi A; Ricci U; Ricotti G; Biondi C; Scarselli B; Vieri F; Scarnato P; Gori F; Sereni A
Am J Med Genet; 1999 May; 84(3):300-3. PubMed ID: 10331612
[TBL] [Abstract][Full Text] [Related]
19. Premutations of FMR1 CGG repeats are not related to idiopathic premature ovarian failure in Iranian patients: A case control study.
Asadi R; Omrani MD; Ghaedi H; Mirfakhraie R; Azargashb E; Habibi M; Pouresmaeili F
Gene; 2018 Nov; 676():189-194. PubMed ID: 30030199
[TBL] [Abstract][Full Text] [Related]
20. Association of FMR1 repeat size with ovarian dysfunction.
Sullivan AK; Marcus M; Epstein MP; Allen EG; Anido AE; Paquin JJ; Yadav-Shah M; Sherman SL
Hum Reprod; 2005 Feb; 20(2):402-12. PubMed ID: 15608041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]